Medscape8d
Some Patients — And Doctors — Turn to Microdosing GLP-1s
Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...
HME News14d
ResMed moves to address ‘educational gap’ on PAP devices, GLP-1s
SAN DIEGO – In the wake of the U.S. Food and Drug Administration’s approval of Zepbound to treat moderate to severe obstructive sleep apnea, ResMed is ramping up its education to high-volume ...
Associated Press14d
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
Copyright 2025 The Associated Press. All Rights Reserved. A new poll from The Associated Press-NORC Center for Public Affairs Research looks at what U.S. adults think ...
bnnbloomberg14d
Novo Nordisk Shares Have a Long Road Back from 40% Slump
The experimental CagriSema shot missed Novo’s own expectations for weight loss and performed roughly in-line with Eli Lilly & Co.’s Zepbound, which is already ... scheduled for Feb. 5, to provide a ...
dermatologyadvisor15d
FDA Alert: Pulmonology Drug Approvals, Recalls, and Device Updates
5-6 The approval was based on data from the randomized, phase 3 eXalt3 study (ClinicalTrials.gov Identifier: NCT02767804), which evaluated the safety and efficacy of ensartinib by comparing ensartinib ...
MassDevice15d
ResMed revenue up 10% in Q2 — but GLP-1 questions remain
The results, out after market close yesterday evening, came more than a month after the FDA approved Eli Lilly’s GLP-1 drug Zepbound (tirzepatide) as the first and only prescription drug to ...
Pharmaceutical Technology15d
Top 20 biopharma companies’ market caps rise 1.7% over 2024 amid policy
Despite this, recent results from the SURMOUNT-5 Phase 3b trial revealed that Zepbound delivered a 47% greater relative weight loss compared to rival Novo Nordisk’s Wegovy (semaglutide), further ...
Daily Mail17d
French police probe death threats against judge and prosecutors in Marine Le Pen £5.6m corruption case which could bar far-right leader from standing in next presidential election
An investigation has been launched by French police after a judge and two prosecutors involved in the corruption trial of far-right leader Marine Le Pen received death threats. The case could see ...
Nasdaq17d
What Does the Future Hold for Eli Lilly?
With its offering of tirzepatide (branded as Mounjaro and Zepbound), Eli Lilly and Co ... for which the company recently paid $2.5 billion. All of this is to say that, despite the massive ...
AOL21d
Prediction: 3 Stocks That'll Be Worth More Than Berkshire Hathaway 5 Years From Now
That honor still belongs to Apple with a market cap if just under $3.5 trillion. That's followed ... Mounjaro along with Zepbound -- both of which are the exact same molecular formula, called ...
BioWorld22d
Lilly’s Zepbound outpaces Wegovy as December logs 212 trial updates
Eli Lilly and Co. reported that its FDA-approved weight-loss drug Zepbound (tirzepatide) outperformed Novo Nordisk A/S’s Wegovy (semaglutide) in the phase IIIb Surmount-5 trial.
Healthline23d
Can You Use a Breast Pump to Induce Labor?
Using a breast pump may help start labor contractions for some full-term pregnant women or for those past their due dates. The theory is that nipple stimulation from the breast pump increases the ...